Key result
Myeloid cells, specifically CD301b+ mononuclear phagocytes, play a causal role in the initiation and progression of autoimmune mitral valve inflammation and fibrosis.
Answers are grounded in this paper and cite their sources.
Article, see p 2478 Mitral valve disease is a degenerative cardiac pathology that increases markedly with age in the Western Hemisphere. Rheumatic heart disease is another frequent cause of valve pathology, in particular, in developing countries. In this condition, valvular damage arises from autoimmune responses after group A streptococcal infection, leading first to mitral valve insufficiency and, at later stages, to stenosis. Once the disease is established, therapeutic options are currently limited to either symptomatic treatment or invasive surgical procedures.1 The central importance of the adaptive immune response for developing rheumatic heart disease is well known: B cells produce antibodies directed against streptococcal epitopes. Those antibodies cross-react with antigens such as laminin in the valve endocardium, ultimately leading to endothelial cell activation and vascular cell adhesion molecule expression. This promotes the entry of T cells, which likely destroy valvular tissue by secretion of proinflammatory cytokines.1 In this issue of Circulation , Meier et al2 describe for the first time the causal involvement of innate immune cells in the pathogenesis of mitral valve disease. The authors conducted their studies in K/B.g7 T-cell receptor transgenic mice (TCR mice) that express a T-cell receptor that recognizes the self-peptide glucose-6-phosphate isomerase. The resulting autoantibody production causes erosive polyarthritis and mitral valve inflammation. Mitral valves become fibrotic and accumulate myeloid cells that express the fractalkine receptor CX3CR1. Genetic deletion of CX3CR1 protects mice from valve fibrosis and inflammation, likely because this receptor regulates myeloid cell migration and survival.3 Using multicolor flow cytometry, the authors identify a CD301b/MGL2 mononuclear cell population as a key protagonist of mitral valve disease in TCR mice. They characterize this population as CXC3CR1+CD64+CD301b+ mononuclear phagocytes and ascribe to them …
No takes yet. Share an insight, caveat, or question.
Cremer et al. (2018) conducted an editorial in Mitral valve disease. Myeloid cells (CD301b+ mononuclear phagocytes) was evaluated. Myeloid cells, specifically CD301b+ mononuclear phagocytes, play a causal role in the initiation and progression of autoimmune mitral valve inflammation and fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: